Colon Cancer Diagnosis and Therapy: Volume 1
Editat de Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarmaen Limba Engleză Hardback – 10 iun 2021
Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis.
This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 1046.91 lei 6-8 săpt. | |
| Springer International Publishing – 10 iun 2021 | 1046.91 lei 6-8 săpt. | |
| Springer International Publishing – 4 iun 2021 | 1230.35 lei 6-8 săpt. |
Preț: 1046.91 lei
Preț vechi: 1102.02 lei
-5% Nou
Puncte Express: 1570
Preț estimativ în valută:
200.39€ • 215.46$ • 167.06£
200.39€ • 215.46$ • 167.06£
Carte tipărită la comandă
Livrare economică 19 decembrie 24 - 02 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030633684
ISBN-10: 3030633683
Ilustrații: XII, 369 p. 20 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.71 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030633683
Ilustrații: XII, 369 p. 20 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.71 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
V-ar putea interesa
-
-23%Preț: 817.35 lei1054.91 lei -
-9%Preț: 741.06 lei814.35 lei -
-9%Preț: 741.56 lei814.91 lei -
Radiation Toxicity: A Practical Medical GuideWilliam Small-5%Preț: 852.51 lei897.37 lei -
Bioinformatics for Cancer Immunotherapy: Methods and ProtocolsSebastian Boegel-5%Preț: 786.38 lei827.77 lei -
Innate Lymphoid Cells: Methods and ProtocolsShoba Amarnath-5%Preț: 708.37 lei745.66 lei -
-5%Preț: 1041.08 lei1095.86 lei -
Virtual EndoscopyDidier Buthiau-5%Preț: 1034.10 lei1088.52 lei -
Esophageal Cancer: Prevention, Diagnosis and TherapyNabil F. Saba-5%Preț: 715.08 lei752.71 lei -
-5%Preț: 1079.76 lei1136.58 lei -
Circulating Tumor Cells in Breast Cancer Metastatic DiseaseRoberto Piñeiro-5%Preț: 663.37 lei698.28 lei -
Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal CancersGanji Purnachandra Nagaraju-5%Preț: 1039.31 lei1094.02 lei -
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted TherapyIago Dillion Lima Cavalcanti-5%Preț: 481.89 lei507.24 lei -
Colon Cancer Diagnosis and Therapy Vol. 3Dhananjay Shukla-5%Preț: 1530.59 lei1611.14 lei -
The Molecular Genetics of Lung CancerDavid N Cooper-5%Preț: 743.60 lei782.73 lei -
Chronic Lymphocytic LeukemiaFederico Caligaris-Cappio-5%Preț: 1031.53 lei1085.83 lei -
Cancer PreventionH.-J. Senn-5%Preț: 1514.63 lei1594.34 lei -
Role of Tyrosine Kinases in Gastrointestinal MalignanciesGanji Purnachandra Nagaraju-5%Preț: 686.27 lei722.39 lei -
Practical Radiation OncologySupriya Mallick-5%Preț: 565.64 lei595.40 lei -
-5%Preț: 1011.74 lei1064.98 lei -
-5%Preț: 983.39 lei1035.14 lei -
Theranostics Approaches to Gastric and Colon CancerGanji Seeta Rama Raju-5%Preț: 661.45 lei696.27 lei -
Novel therapeutic approaches for gastrointestinal malignanciesGanji Purnachandra Nagaraju-5%Preț: 676.78 lei712.39 lei -
Immunotherapy for Gastrointestinal MalignanciesRamakrishna Vadde-5%Preț: 1213.87 lei1277.77 lei
Cuprins
1.Epidimology of colorectal cancer
2.Colorectal cancer: A model for the study of cancer immunology
3.Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients: An Emphasis on Colorectal Cancer
4. Potential role of NMR and MRI in colon cancer
5.Role of micro-RNA in-situ hybridization in colon cancer diagnosis
6.Role of epigenetics in colorectal cancer
7.Exosomal biomarkers in colorectal cancer
8.Biomarkers as putative therapeutic targets in colorectal cancer
9. Proteins involved in colorectal cancer: Identification strategies and possible roles
10. Short-chain fatty acids as therapeutic agents in colon malignancies
11. Targeting of angiogenesis for colorectal cancer therapy
12. Anti‐inflammatory molecular mechanism and contribution of drug transport molecules in colorectal cancer cells
13. Emerging role of circulating tumour DNA in treatment response prognosis in colon cancer
14. Immuno-modulating mediators of colon cancer as immunotherapeutic: mechanism and potential
15. Immune checkpoint inhibitors as armor for targeted immunotherapy of colorectal cancer
16. Examining the role of the MACC1 gene in colorectal cancer metastasis
Index
Notă biografică
Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Nagaraju obtained his MSc and PhD, both in Biotechnology from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. Dr. Nagaraju received his D.Sc. from Berhampur University in Berhampur, Odisha, India. Nagaraju's research focuses on translational research in gastrointestinal malignancies. He has published over 100 research papers in highly respected international journals and has presented more than 50 abstracts at various national and international conferences. He is the author and editor of several books. Dr. Nagaraju is an editorial board member of several internationally recognized academic journals, and is an associate member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He is a member of the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), the Science Advisory Board, The RNA Society and the American Association of Cancer Research (AACR).
Dr. Dhananjay Shukla is an Assistant Professor in the Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A Central University) in India. Dr. Shukla received his PhD in Biotechnology from Defense Institute of Physiology and Allied Science, New Delhi, India. Dr. Shukla has expertise in cancer physiology and has published more than 25 research papers in various highly reputed international journal. He has presented and been invited to lecture at a number national and international conferences.
Dr. Naveen Kumar Vishvakarma is an Assistant Professor in the Department of Biotechnology at Guru Ghasidas Vishwavidyalaya (A Central University) in India. Dr. Vishvakarma received his PhD in Biotechnology from Banaras Hindu University, Varanasi, India. He has published more than 20 research papers in highly reputed journals on various aspects of cancer biology. He has written a number of book chapters for international publishers and presented abstract at national and international conferences.
Textul de pe ultima copertă
Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis.
This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
Caracteristici
Describes the causes and early diagnostic tools for effective use of current and future therapeutic regimens
Focuses on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer
Provides in-depth information about existing and potential biomarkers for early diagnosis
Focuses on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer
Provides in-depth information about existing and potential biomarkers for early diagnosis